Related Experiment Videos
Effects of thiazolidinediones on cardiovascular risk factors
Biswanath P Gouda1, Sunil Asnani, Vivian A Fonseca
1Department of Medicine, Section of Endocrinology, Tulane University Health Sciences Center, New Orleans, LA, USA.
Comprehensive Therapy
|January 1, 2003
Abstract:
The thiazolidinediones are the insulin sensitizers used in the management of Type 2 diabetes mellitus. These drugs can potentially decrease the risk of cardiovascular disease by correcting the different components of the insulin resistance syndrome.